Portage Biotech Inc (NASDAQ:PRTG) has a beta value of 1.51 and has seen 29.8 million shares traded in the last trading session. The company, currently valued at $10.76M, closed the last trade at $9.60 per share which meant it gained $4.89 on the day or 103.82% during that session. The PRTG stock price is -139.69% off its 52-week high price of $23.01 and 78.12% above the 52-week low of $2.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.24 million shares traded. The 3-month trading volume is 101.95K shares.
The consensus among analysts is that Portage Biotech Inc (PRTG) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Portage Biotech Inc (NASDAQ:PRTG) trade information
Sporting 103.82% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PRTG stock price touched $9.60 or saw a rise of 27.27%. Year-to-date, Portage Biotech Inc shares have moved 85.69%, while the 5-day performance has seen it change 131.33%. Over the past 30 days, the shares of Portage Biotech Inc (NASDAQ:PRTG) have changed 121.20%. Short interest in the company has seen 13819.0 shares shorted with days to cover at 0.69.
Wall Street analysts have a consensus price target for the stock at $4.88, which means that the shares’ value could drop -96.72% from current levels. The projected low price target is $4.5 while the price target rests at a high of $5.25. In that case, then, we find that the current price level is 45.31% off the targeted high while a plunge would see the stock lose 53.12% from current levels.
Portage Biotech Inc (PRTG) estimates and forecasts
The company’s shares have gained 37.73% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -48.08% over the past 5 years.
PRTG Dividends
Portage Biotech Inc is expected to release its next earnings report on 2024-Feb-27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Portage Biotech Inc (NASDAQ:PRTG)’s Major holders
Insiders own 51.38% of the company shares, while shares held by institutions stand at 6.20% with a share float percentage of 12.74%. Investors are also buoyed by the number of investors in a company, with Portage Biotech Inc having a total of 20.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 1.5 million shares worth more than $0.32 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 7.1866% of shares outstanding.
The other major institutional holder is , with the holding of over 0.3 million shares as of 2024-06-30. The firm’s total holdings are worth over $71514.0 and represent 1.4247% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and Guggenheim Active Allocation Fund . As of Dec 31, 2024 , the former fund manager holds about 0.01% shares in the company for having 107.0 shares of worth $1027.0 while later fund manager owns 1.0 shares of worth $9.0 as of Nov 30, 2024 , which makes it owner of about 0.00% of company’s outstanding stock.
